
What’s The Opiant CVR Worth? (NASDAQ:OPNT)
Solskin Opiant (NASDAQ:OPNT) is being acquired for $20 a share, as this article previously discussed. Since then the Hart-Scott-Rodino waiting period expired and CFIUS approval was granted, so it is likely that after a shareholder […]